Newswise — To celebrate Breast Cancer Awareness Month, The University of New Mexico Lobos and UNM Comprehensive Cancer Center are sponsoring the “Lobos Love Pink” Football game on Friday, October 20, 2017. The Lobos will face the Colorado State Rams in Dreamstyle Stadium beginning at 8:15 pm. A ceremony during a game break will honor those who continue to fight breast cancer, celebrate survivors, and remember those who have lost their battle.

About one in eight women in the United States will be diagnosed with breast cancer during her lifetime. “Fortunately in breast cancer,” says Ursa Brown-Glaberman, MD, “most patients are cured of their disease. The key is to find the disease early when it is still curable.” Brown-Glaberman is a breast cancer specialist at the UNM Comprehensive Cancer Center and co-leads the Breast team. Breast team member, Amy Tarnower, MD, will represent the faculty of the UNM Cancer Center at the football game. The UNM Cancer Center will host an invitation-only pre-game reception for breast cancer survivors and their families.

“We thank the Lobo Football team for their support and participation,” says Cheryl Willman, MD, Director and CEO of the UNM Cancer Center. “Lobos Love Pink games help us to raise awareness for screening, which helps us to save lives.”

About the UNM “Lobos Love Pink” Football Game

The University of New Mexico Lobos will kick off against the Colorado State Rams on Friday, October 20, 2017, at 8:15 pm in Dreamstyle Stadium, 1414 University Blvd SE, Albuquerque, NM 87106. If you are interested in purchasing tickets in advance, please call the Lobo Ticket Office at 505-925-LOBO or visit Wear pink to the game and purchase a ticket for only $10!

About the UNM Comprehensive Cancer Center

The University of New Mexico Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Cancer Center in a 500-mile radius. Its 125 board-certified oncology specialty physicians include cancer surgeons in every specialty (abdominal, thoracic, bone and soft tissue, neurosurgery, genitourinary, gynecology, and head and neck cancers), adult and pediatric hematologists/medical oncologists, gynecologic oncologists, and radiation oncologists. They, along with more than 500 other cancer healthcare professionals (nurses, pharmacists, nutritionists, navigators, psychologists and social workers), provided cancer care for nearly 60 percent of the adults and children in New Mexico affected by cancer. They treated 11,249 patients in 84,875 ambulatory clinic visits in addition to in-patient hospitalizations at UNM Hospital. These patients came from every county in the State. More than 12 percent of these patients participated in cancer clinical trials testing new cancer treatments and 35 percent of patients participated in other clinical research studies, including tests of novel cancer prevention strategies and cancer genome sequencing. The 130 cancer research scientists affiliated with the UNMCCC were awarded almost $60 million in federal and private grants and contracts for cancer research projects and published 301 high quality publications. Promoting economic development, they filed more than 30 new patents in FY16, and since 2010, have launched 11 new biotechnology start-up companies. Scientists associated with the UNMCCC Cancer Control & Disparities have conducted more than 60 statewide community-based cancer education, prevention, screening, and behavioral intervention studies involving more than 10,000 New Mexicans. Finally, the physicians, scientists and staff have provided education and training experiences to more than 230 high school, undergraduate, graduate, and postdoctoral fellowship students in cancer research and cancer health care delivery. Learn more at